Hepatic metabolism of oxidatively modified apo E-free high-density lipoproteins. 1998

J G DeLamatre, and D M Gabaldon, and C S Arnold, and T G Sarphie, and C A Hornick
Department of Physiology, Louisiana State University Medical Center, New Orleans 70112, USA.

OBJECTIVE The metabolism of rat apo E-free high-density lipoproteins (HDL) was contrasted with oxidatively modified apo E-free high-density lipoproteins (OX-HDL) in the rat hepatoma cell, Fu5AH. RESULTS When 10-100 microg/ml [125I]-HDL or [125I]-OX-HDL were incubated with cells for 4 h at 37 degrees C, cellular uptake of oxidized lipoproteins was twice control. In contrast, protein degradation was equal. [125I]-HDL or [125I]-OX-HDL were incubated with the cells for 4 h followed by a 4 h chase with unlabeled HDL and OX-HDL, respectively. In these experiments, 80% of [125I]-HDL was resecreted from the cell within 30 min while 50% of [125I]-OX-HDL was retained by the cell after 2 h. Electron microscopy was used to determine if the OX-HDL was retained in lysosomes. Cells were incubated with gold-labeled OX-HDL, and lysosomes were stained with acid phosphatase. Gold-labeled OX-HDL was abundant in intracellular vesicles that were not reactive to acid phosphatase. However, vesicles with a high content of OX-HDL frequently stained positively for 3,3'-diaminobenzidine, a stain that reacts with catalase and is used to detect peroxisomes. CONCLUSIONS The present evidence indicates that the cellular metabolism of OX-HDL is different from that of unmodified HDL.

UI MeSH Term Description Entries
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

J G DeLamatre, and D M Gabaldon, and C S Arnold, and T G Sarphie, and C A Hornick
January 1985, Arteriosclerosis (Dallas, Tex.),
J G DeLamatre, and D M Gabaldon, and C S Arnold, and T G Sarphie, and C A Hornick
April 1989, Atherosclerosis,
J G DeLamatre, and D M Gabaldon, and C S Arnold, and T G Sarphie, and C A Hornick
October 1999, European journal of clinical investigation,
J G DeLamatre, and D M Gabaldon, and C S Arnold, and T G Sarphie, and C A Hornick
October 1999, European journal of clinical investigation,
J G DeLamatre, and D M Gabaldon, and C S Arnold, and T G Sarphie, and C A Hornick
January 1985, Arteriosclerosis (Dallas, Tex.),
J G DeLamatre, and D M Gabaldon, and C S Arnold, and T G Sarphie, and C A Hornick
January 1995, Diabetes,
J G DeLamatre, and D M Gabaldon, and C S Arnold, and T G Sarphie, and C A Hornick
October 1987, The Journal of biological chemistry,
J G DeLamatre, and D M Gabaldon, and C S Arnold, and T G Sarphie, and C A Hornick
July 1989, Journal of lipid research,
J G DeLamatre, and D M Gabaldon, and C S Arnold, and T G Sarphie, and C A Hornick
May 1999, Expert opinion on investigational drugs,
J G DeLamatre, and D M Gabaldon, and C S Arnold, and T G Sarphie, and C A Hornick
June 2009, Biochimica et biophysica acta,
Copied contents to your clipboard!